Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 231,270,909 papers from all fields of science
Search
Sign In
Create Free Account
aliskiren / Hydrochlorothiazide
Known as:
ALISKIREN/HYDROCHLOROTHIAZIDE
, aliskiren and hydrochlorothiazide
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Hydrochlorothiazide
aliskiren
aliskiren 150 MG / Hydrochlorothiazide 25 MG Oral Tablet
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Efficacy of Aliskiren/Hydrochlorothiazide Combination for the Treatment of Hypertension: A Meta-Analytical Revision
M. Morgado
,
Sandra A Rolo
,
M. Castelo-Branco
2017
Corpus ID: 39072255
Hypertension is a major risk factor in the development of cardiovascular disease, with myocardial infarction, stroke and renal…
Expand
Review
2013
Review
2013
GW24-e1158 Aliskiren/amlodipine versus aliskiren/hydrochlorothiazide in hypertension: Indirect-comparison meta-analysis of randomised controlled trials
Gao Dengfeng
,
Liu Yang
,
Niu Xiaolin
,
Y. Rui
,
Meng Zhe
Heart
2013
Corpus ID: 72816620
Objectives Aliskiren, a direct renin inhibitor, is effective for reducing blood pressure (BP) in patients with hypertension when…
Expand
2009
2009
Antihypertensive efficacy and tolerability of aliskiren/hydrochlorothiazide (HCT) single-pill combinations in patients who are non-responsive to HCT 25 mg alone*
M. Blumenstein
,
J. Romaszko
,
+4 authors
J. Zhang
Current Medical Research and Opinion
2009
Corpus ID: 44676569
ABSTRACT Objective: Thiazide diuretics such as hydrochlorothiazide (HCT) are a widely used first-line treatment for hypertension…
Expand
2008
2008
Aliskiren/hydrochlorothiazide (Tekturna HCT) for hypertension.
The Medical letter on drugs and therapeutics
2008
Corpus ID: 20025019
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required